Showing results (401-410 of 501) with videos related to

Sort By:
Pageof 51
Nature Structural Biology|March 31, 2000
Structure of a novel leech carboxypeptidase inhibitor determined free in solution and in complex with human carboxypeptidase A2D Reverter, C Fernández-Catalán, R Baumgartner, et al.
Thrombosis and Haemostasis|July 4, 2001
Fine mapping of inhibitory anti-factor V antibodies using factor V C2 domain mutants. Identification of two antigenic epitopes involved in phospholipid bindingT Izumi, S W Kim, A Greist, et al.
Angewandte Chemie (International Ed. in English)|September 15, 2017
Synthesis of Acylborons by Ozonolysis of Alkenylboronates: Preparation of an Enantioenriched Amino Acid AcylboronateJumpei Taguchi, Toshiki Ikeda, Rina Takahashi, et al.
ACS Pharmacology & Translational Science|February 20, 2025
Natural and Synthetic LDL-Based Imaging Probes for the Detection of Atherosclerotic PlaquesAlessandro Fracassi, Hui Qiao, Andrew N Lowell, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 29, 2012
Effect of sitagliptin on post-prandial glucagon and GLP-1 levels in patients with type 1 diabetes: investigator-initiated, double-blind, randomized, placebo-controlled trialSatish K Garg, Emily G Moser, Bruce W Bode, et al.
Chemical Science|June 14, 2021
An integrated console for capsule-based, automated organic synthesisTuo Jiang, Samuele Bordi, Angus E McMillan, et al.
Diabetes Care|May 10, 2017
Faster Aspart Versus Insulin Aspart as Part of a Basal-Bolus Regimen in Inadequately Controlled Type 2 Diabetes: The onset 2 TrialKeith Bowering, Christopher Case, John Harvey, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 11, 2000
(4-aminomethyl)phenylguanidine derivatives as nonpeptidic highly selective inhibitors of human urokinaseS Sperl, U Jacob, N Arroyo de Prada, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 13, 2016
The Efficacy of IDegLira (Insulin Degludec/Liraglutide Combination) in Adults with Type 2 Diabetes Inadequately Controlled with a GLP-1 Receptor Agonist and Oral Therapy: DUAL III Randomized Clinical TrialSultan Linjawi, Bruce W Bode, Louis B Chaykin, et al.
Diabetes Care|May 12, 2019
Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec, in Children and Adolescents With Type 1 Diabetes: The onset 7 TrialBruce W Bode, Violeta Iotova, Margarita Kovarenko, et al.
Pageof 51